Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Prachi Wickremasingha"'
Autor:
Emmanuel Roilides, John S. Bradley, Julia Lonchar, Jennifer A. Huntington, Prachi Wickremasingha, Feng-Hsiu Su, Christopher J. Bruno, Matthew G. Johnson
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 5 (2023)
ABSTRACT Ceftolozane/tazobactam is approved for the treatment of patients from birth to
Externí odkaz:
https://doaj.org/article/46e4bb8e3e354f6087e7fa2f5eb88afd
Autor:
Ben Tao, Joseph R. Walker, Prachi Wickremasingha, James Lee, Douglas Wight, Ling He, Jeanne Mendell-Harary
Publikováno v:
The Journal of Clinical Pharmacology. 54:61-69
Bile acid sequestrants can potentially bind to concomitant drugs. Single-dose studies evaluated the effects of colesevelam on the pharmacokinetics of glimepiride, glipizide extended-release (ER), and olmesartan medoxomil. Each study enrolled healthy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2384c6c8796b6af4d45dff486d01d89
https://doi.org/10.1002/jcph.180
https://doi.org/10.1002/jcph.180
Publikováno v:
The Journal of Clinical Pharmacology. 49:103-108
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c95ea7c21bd6246b002a13125920bf74
https://doi.org/10.1177/0091270008326717
https://doi.org/10.1177/0091270008326717
Autor:
Victor Dishy, Dolly A. Parasrampuria, Jarema Kochan, Daniel Weiss, Minggao Shi, Ling He, Prachi Wickremasingha, Karen Brown
Publikováno v:
Thrombosis research. 136(4)
Background Edoxaban, a direct factor Xa inhibitor, is a once-daily, non-vitamin K antagonist oral anticoagulant. There is no established method to reverse the activity of non-vitamin K oral anticoagulants in cases of hemorrhage or urgent surgery. Thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5620cf8545372d3b83ff1d882d61dd8
https://pubmed.ncbi.nlm.nih.gov/26298619
https://pubmed.ncbi.nlm.nih.gov/26298619
Autor:
Ling He, Dolly A. Parasrampuria, Shuquan Chen, Thomas Marbury, Nobujo Matsushima, Prachi Wickremasingha, Victor Dishy, Karen Brown
Publikováno v:
Thrombosis and haemostasis. 113(4)
SummaryEdoxaban is an oral, direct, once-daily, factor Xa inhibitor developed for stroke prevention in patients with atrial fibrillation and for the treatment and secondary prevention of recurrent thromboembolism in patients with acute symptomatic ve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb510aaaec9a61d55a1e683533d52467
https://pubmed.ncbi.nlm.nih.gov/28367580
https://pubmed.ncbi.nlm.nih.gov/28367580
Autor:
James Lee, Jeanne Mendell-Harary, Prachi Wickremasingha, Ben Tao, Joseph R. Walker, Ling He, Douglas Wight
Publikováno v:
Diabetes research and clinical practice. 104(3)
Aims Drug interactions with bile acid sequestrants are primarily due to the potential of these agents to bind to concomitant drugs. Six clinical studies were performed to determine the effects of colesevelam on the pharmacokinetics of aspirin, atenol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b817e5fd17352f865e060f5ba26b607
https://pubmed.ncbi.nlm.nih.gov/24721587
https://pubmed.ncbi.nlm.nih.gov/24721587
Autor:
Ling, He, Prachi, Wickremasingha, James, Lee, Ben, Tao, Jeanne, Mendell-Harary, Joseph, Walker, Douglas, Wight
Publikováno v:
Journal of clinical pharmacology. 54(1)
Bile acid sequestrants can potentially bind to concomitant drugs. Single-dose studies evaluated the effects of colesevelam on the pharmacokinetics of glimepiride, glipizide extended-release (ER), and olmesartan medoxomil. Each study enrolled healthy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bd870196a1da08b88bb0511a1b01c8e1
https://pubmed.ncbi.nlm.nih.gov/24019110
https://pubmed.ncbi.nlm.nih.gov/24019110
Autor:
Nenad Sarapa, Cindy Yen, Richard Weitzman, NanXiang Ge, Merynda Fuellhart, Prachi Wickremasingha, Julia Lloyd-Parks
Publikováno v:
Antimicrobial agents and chemotherapy. 51(6)
DX-619 is a novel des-fluoro(6)-quinolone with activity against a broad range of bacterial strains, including methicillin-resistant Staphylococcus aureus . The effects of DX-619 on the glomerular filtration rate (GFR) were evaluated because drug-rela
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31cbd828209eda311eb3f291a59b04d7
https://pubmed.ncbi.nlm.nih.gov/17371829
https://pubmed.ncbi.nlm.nih.gov/17371829
Autor:
Minggao Shi, Karen Brown, Dolly A. Parasrampuria, Prachi Wickremasingha, Victor Dishy, Jarema Kochan
Publikováno v:
Journal of the American College of Cardiology. (12):A2095
Edoxaban (Edox) is a novel oral, once-daily, direct factor Xa inhibitor currently under clinical investigation. To date, there is no established paradigm to reverse Edox activity in cases of clinically relevant bleeding. We evaluated the use of 3-fac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab11087397a050c5221089d4c26800a8